Posted in | News | Iron Ore

India's Zamin Ferrous Pulls Back from Minera Aratiri Project in Uruguay

Indian iron-ore mining group Zamin Ferrous Resources was to develop the Minera Aratiri project in Uruguay, but has now downgraded the project on its international priority list from first to  fourth position. The $1 billion that was slated by the company for the project is now going to be put to better use in other ongoing projects.

There are about 250 million tons of iron ore which have already been established at the project. A final recoverable quantity may be as high as 1 billion tons.

A controversial 130 mile slurry pipeline to transport the ore to a new port on the Atlantic coast is in early development stages and is considered by the president Jose Mujica to be the solution to open up the underdeveloped portion of the country to new business opportunities. However the project has faced considerable opposition from local residents and environmental groups.

As per the opposing factions the large-scale exploitation of the mine is likely to ruin vast tracts of pristine environment on one hand and is not likely to benefit the economy of the region to the extent that is claimed in the feasibility study and reports. The intense debate in the South American country is ultimately what influenced Zamin Ferrous to downgrade the priority of Minera Aratiri.

The general manager for Zamin Ferrous Respources' Uruguay unit Aratiri, Fernando Puntigliano, said that the project was put on the back burner mainly because of the political controversy over its feasibility and delays already affecting a completion schedule. All the noise is impacting this and other investments he added.

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, March 19). India's Zamin Ferrous Pulls Back from Minera Aratiri Project in Uruguay. AZoMining. Retrieved on September 22, 2024 from https://www.azomining.com/News.aspx?newsID=4652.

  • MLA

    Scanlon, Joel. "India's Zamin Ferrous Pulls Back from Minera Aratiri Project in Uruguay". AZoMining. 22 September 2024. <https://www.azomining.com/News.aspx?newsID=4652>.

  • Chicago

    Scanlon, Joel. "India's Zamin Ferrous Pulls Back from Minera Aratiri Project in Uruguay". AZoMining. https://www.azomining.com/News.aspx?newsID=4652. (accessed September 22, 2024).

  • Harvard

    Scanlon, Joel. 2019. India's Zamin Ferrous Pulls Back from Minera Aratiri Project in Uruguay. AZoMining, viewed 22 September 2024, https://www.azomining.com/News.aspx?newsID=4652.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.